Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI to deploy the technology across its operations as it looks to keep pace with rapid expansion in the obesity drug market. The Danish company announced in a statement on Tuesday that it would use AI to analyze complex datasets, identify promising drug candidates…
Politics
·
Novo Nordisk partners with OpenAI in weight loss drug race
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Farage vows to ban foreign nationals from social housing
Farage vows to ban foreign nationals from social housing7 minutes agoShareSaveAdd as preferred on GoogleKate Whannel,Pol...
CitrixNews Staff
·
23 minutes ago
Politics
Former Iran deal negotiator: 60 days is a ‘pretty short period of time’ for nuclear talks
Former Deputy Secretary of State Wendy Sherman on Sunday said that a 60-day timeframe outlined in a draft peace plan for...
CitrixNews Staff
·
55 minutes ago
Politics
Mullin says ICE ‘only’ deployed at midterm polls if ‘threat’ arises
Homeland Security Secretary Markwayne Mullin said Sunday that Immigration and Customs Enforcement would “only” be deploy...
CitrixNews Staff
·
59 minutes ago
Politics
Senate Republican doubts Israel trying to ‘scuttle’ US-Iran deal
Sen. Deb Fischer (R-Neb.) on Sunday said she doubts that Israel is trying to “scuttle” an emerging deal between the U.S....
CitrixNews Staff
·
1 hour ago